Découvrez le nouveau Chem-Impex : là où l'innovation commence par une liaison.

Catalog Number:
38205
CAS Number:
124436-59-5
Pirodavir
Purity:
≥ 95 % (HPLC)
Synonym(s):
4-[2-[1-(6-méthyl-3-pyridazinyl)-4-pipéridinyl]éthoxy]benzoate d'éthyle, Ester éthylique de l'acide 4-[2-[1-(6-méthyl-3-pyridazinyl)-4-pipéridinyl]éthoxy]benzoïque
Documents
$233.55 /10 mg
Taille
Request Bulk Quote
Informations sur le produit

Pirodavir is a potent antiviral compound recognized for its efficacy against a range of viral infections, particularly in the context of respiratory viruses. Its unique structure, characterized by the presence of a piperidine ring and a pyridazine moiety, enhances its interaction with viral targets, making it a valuable candidate in antiviral research and therapeutic applications. Pirodavir has shown promise in inhibiting viral replication, which positions it as a potential treatment option for conditions such as influenza and other respiratory tract infections.

Researchers and industry professionals will appreciate Pirodavir's favorable pharmacokinetic properties, which facilitate its absorption and distribution in the body, leading to effective therapeutic outcomes. Its versatility allows for exploration in various formulations, including oral and injectable forms, catering to diverse patient needs. As the demand for effective antiviral agents continues to grow, Pirodavir stands out for its potential to contribute significantly to the development of innovative antiviral therapies, making it an essential compound for laboratories and pharmaceutical companies focused on infectious disease management.

Numéro CAS 
124436-59-5
Formule moléculaire
C21H27N3O3
Poids moléculaire 
369.47
Point de fusion 
124 - 126 °C
Informations générales
Numéro CAS 
124436-59-5
Formule moléculaire
C21H27N3O3
Poids moléculaire 
369.47
Point de fusion 
124 - 126 °C
Propriétés
Informations complémentaires sur la propriété à venir prochainement !
-
Sécurité et réglementation
Matières dangereuses
-
Antibiotique
-
Réglementé par la DEA
Non
Avertissements 
-
Applications

Pirodavir is widely utilized in research focused on:

  • Antiviral Research: Pirodavir has shown effectiveness against various viral infections, making it a valuable compound in the development of antiviral therapies. Researchers are exploring its potential to combat respiratory viruses, which can lead to significant advancements in public health.
  • Pharmaceutical Development: This compound is being investigated for its role in formulating new medications. Its unique structure allows for modifications that can enhance drug efficacy and reduce side effects, providing a competitive edge in drug design.
  • In Vitro Studies: Pirodavir is frequently used in laboratory settings to study viral replication mechanisms. This application aids researchers in understanding how viruses operate, ultimately contributing to the development of targeted treatments.
  • Combination Therapies: The compound is being evaluated for use in combination with other antiviral agents. This approach can enhance therapeutic outcomes by leveraging synergistic effects, which may lead to more effective treatment regimens.
  • Clinical Trials: Pirodavir is currently involved in various clinical trials aimed at assessing its safety and efficacy in humans. This research is critical for bringing new antiviral solutions to market, addressing unmet medical needs.

Citations